首頁 > 市場調查報告書 > 醫療設備

導管

市場調查報告書

商品編碼

1489203

全球可生物分解支架市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Biodegradable Stents Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年05月01日 | 出版商:

Value Market Research | 英文 167 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球生物分解支架市場需求預計將從2023年的3.5356億美元達到近7.1387億美元的市場規模，2024-2032年研究期間複合年成長率為8.12%。

可生物分解支架是用於治療冠狀動脈疾病 (CAD) 和周邊動脈疾病 (PAD) 等動脈狹窄或阻塞的醫療器材。與永久植入體內的傳統金屬支架不同，這些支架的設計會隨著時間的推移逐漸分解並被身體吸收。這種創新方法降低了與永久植入物相關的長期併發症的風險，例如再狹窄和血栓形成。這些支架促進自然血管癒合和動脈功能恢復，同時最大限度地減少長期抗血小板治療的需要。它們為需要血管介入治療的患者提供了一個有前景的解決方案，提供有效的治療，降低長期風險並改善臨床結果。

市場動態

全球冠狀動脈疾病 (CAD) 和周邊動脈疾病 (PAD) 的流行，加上對微創治療的需求不斷增加，正在推動可生物分解支架作為傳統金屬支架的替代品。隨著患者和醫療保健提供者尋求更安全、更有效的解決方案來恢復血流和防止動脈阻塞，這些支架具有多種優勢，包括降低再狹窄風險、改善長期結果和增強血管癒合。此外，支架設計、生物相容性材料和藥物洗脫技術的進步正在推動市場創新，從而能夠開發出具有更高靈活性、可輸送性和藥物釋放動力學的設備，以最佳化臨床結果。

此外，生物可分解支架在複雜病變、分叉和高風險患者群體中的不斷擴大應用正在推動市場成長和多樣化。此外，醫療保健領域對永續性和環境管理的日益重視推動了對可生物分解支架的需求，這些支架最大限度地減少了對長期異物植入的需求並降低了晚期併發症的風險，從而推動了市場擴張。然而，替代支架材料和設計的開發以及介入性心臟病學技術的進步可能會挑戰未來幾年的市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球可生物分解支架市場的各個細分市場進行了包容性評估。可生物分解支架產業的成長和趨勢為本研究提供了整體方法。

市場區隔

可生物分解支架市場報告的這一部分提供了有關國家和區域層面細分市場的詳細資料，從而幫助策略家確定相應產品或服務的目標人群以及即將到來的機會。

按支架類型

冠狀動脈支架
週邊動脈支架

依材料類型

聚合物基
金屬基

按最終用戶

醫院
心導管實驗室
門診手術中心

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲的可生物分解支架市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。可生物分解支架市場的主要參與者包括波士頓科學公司、雅培、Elixir Medical Corporation、Kyoto Medical Planning Co. Ltd.、Biotronik、Terumo Corporation、Biosensors International Group、ELLA - CS SRO、SMT。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：生物可分解支架公司的競爭格局

生物可分解支架市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

頂級公司市佔率分析
市場集中度
Boston Scientific Inc.

公司簡介
公司收入
產品
最近的發展

Abbott

公司簡介
公司收入
產品
最近的發展

Elixir Medical Corporation

公司簡介
公司收入
產品
最近的發展

Kyoto Medical Planning Co. Ltd.

公司簡介
公司收入
產品
最近的發展

Biotronik

公司簡介
公司收入
產品
最近的發展

Terumo Corporation

公司簡介
公司收入
產品
最近的發展

Biosensors International Group

公司簡介
公司收入
產品
最近的發展

ELLA - CS SRO

公司簡介
公司收入
產品
最近的發展

公司簡介
公司收入
產品
最近的發展

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR112114534

The global demand for Biodegradable Stents Market is presumed to reach the market size of nearly USD 713.87 Million by 2032 from USD 353.56 Million in 2023 with a CAGR of 8.12% under the study period 2024-2032.

Biodegradable stents are medical devices used to treat narrowed or blocked arteries in conditions such as coronary artery disease (CAD) & peripheral artery disease (PAD). Unlike traditional metal stents, which remain permanently implanted in the body, these stents are designed to degrade and be absorbed by the body gradually over time. This innovative approach reduces the risk of long-term complications associated with permanent implants, such as restenosis and thrombosis. These stents promote natural vessel healing and restoration of arterial function while minimizing the need for long-term antiplatelet therapy. They offer a promising solution for patients requiring vascular interventions, providing effective treatment with reduced long-term risks and improved clinical outcomes.

MARKET DYNAMICS

The spurring prevalence of coronary artery disease (CAD) and peripheral artery disease (PAD) worldwide, coupled with the escalating demand for minimally invasive treatments, is driving the adoption of biodegradable stents as alternatives to traditional metal stents. As patients & healthcare providers seek safer and more effective solutions for restoring blood flow and preventing artery blockages, these stents offer several advantages, including reduced risk of restenosis, improved long-term outcomes, and enhanced vascular healing. Additionally, advancements in stent design, biocompatible materials, and drug-eluting technologies are driving innovation in the market, enabling the development of devices with improved flexibility, deliverability, and drug release kinetics to optimize clinical outcomes.

Furthermore, the expanding applications of biodegradable stents in complex lesions, bifurcations, and high-risk patient populations are driving market growth and diversification. Moreover, the rising emphasis on sustainability & environmental stewardship in healthcare drives demand for biodegradable stents that minimize the need for long-term foreign body implants and reduce the risk of late complications, driving market expansion. However, the development of alternative stent materials and designs and advancements in interventional cardiology techniques may challenge market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Biodegradable Stents. The growth and trends of Biodegradable Stents industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Biodegradable Stents market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Stent Type

Coronary Artery Stents
Peripheral Artery Stents

By Material Type

Polymer-based
Metal-based

By End-user

Hospitals
Cardiac Catheterization Laboratories
Ambulatory Surgery Centers

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Biodegradable Stents market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Biodegradable Stents market include Boston Scientific Inc., Abbott, Elixir Medical Corporation, Kyoto Medical Planning Co. Ltd., Biotronik, Terumo Corporation, Biosensors International Group, ELLA - CS S.R.O., SMT. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. BIODEGRADABLE STENTS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Stent Type
- 3.7.2 Market Attractiveness Analysis By Material Type
- 3.7.3 Market Attractiveness Analysis By End-user
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL BIODEGRADABLE STENTS MARKET ANALYSIS BY STENT TYPE

5.1. Overview By Stent Type
5.2. Historical and Forecast Data
5.3. Analysis By Stent Type
5.4. Coronary Artery Stents Historic and Forecast Sales By Regions
5.5. Peripheral Artery Stents Historic and Forecast Sales By Regions

6. GLOBAL BIODEGRADABLE STENTS MARKET ANALYSIS BY MATERIAL TYPE

6.1. Overview By Material Type
6.2. Historical and Forecast Data
6.3. Analysis By Material Type
6.4. Polymer-based Historic and Forecast Sales By Regions
6.5. Metal-based Historic and Forecast Sales By Regions

7. GLOBAL BIODEGRADABLE STENTS MARKET ANALYSIS BY END-USER

7.1. Overview By End-user
7.2. Historical and Forecast Data
7.3. Analysis By End-user
7.4. Hospitals Historic and Forecast Sales By Regions
7.5. Cardiac Catheterization Laboratories Historic and Forecast Sales By Regions
7.6. Ambulatory Surgery Centers Historic and Forecast Sales By Regions

8. GLOBAL BIODEGRADABLE STENTS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE BIODEGRADABLE STENTS COMPANIES

9.1. Biodegradable Stents Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF BIODEGRADABLE STENTS INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Boston Scientific Inc.
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Abbott
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Elixir Medical Corporation
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Kyoto Medical Planning Co. Ltd.
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Biotronik
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Terumo Corporation
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Biosensors International Group
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. ELLA - CS S.R.O.
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. SMT
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments